据国家经贸委医药管理司司长于明德介绍,中国医药工业产值已近2 000亿元,医药流通体制改革长期滞后,医药产品经营单位仅限于国有和集体性质的企业,医药商品作为“特殊商品”迟迟未能建立完善的流通和市场竞争机制。中国现有医药批发企业1.6万多家,年营业额超过2 000万元的不足4 According to Yu Mingde, director of the Department of Pharmaceutical Administration of the State Economic and Trade Commission, the output value of the pharmaceutical industry in China has reached nearly 200 billion yuan and the reform of the medical circulation system lags behind. The pharmaceutical product business unit is limited to state-owned and collective enterprises. The pharmaceutical products are regarded as “special commodities ”Delay in establishing a sound mechanism for circulation and market competition. There are more than 16,000 existing pharmaceutical wholesale enterprises in China, with an annual turnover of more than 20 million yuan